NeuroEM Therapeutics, Inc.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device	Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Frontotemporal Lobar Degeneration, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, corticobasal degeneration disorder, dementia, frontotemporal dementia, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, synucleinopathy, tauopathy	Enrolling by invitation	Not applicable	2026-02-05		NCT07222605
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases	Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, corticobasal degeneration disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy, tauopathy	Enrolling by invitation	Not applicable	2025-08-05		NCT07049341

Clinical trials